Skip to main content
Premium Trial:

Request an Annual Quote

NantOmics Buys Remaining Shares of OncoPlex Dx

NEW YORK (GenomeWeb) – NantOmics announced today it has acquired the remaining shares of OncoPlex Diagnostics that it didn't already own. 

The terms of the deal were not disclosed. 

NantOmics is a molecular diagnostics firm and part of the NantWorks network of firms founded by Patrick Soon-Shion. His companies have funded OncoPlex since 2008, NantOmics said. 

OncoPlex operates a CAP-accredited and CLIA-certified laboratory in Rockville, Maryland, where the firm is headquartered, and provides mass spectrometry-based tumor profiling services aimed at improving treatment decisions. 

"With this integration, we have added state-of-the-art discovery tools and a complementary array of molecular diagnostic services and tests," Soon-Shiong said in a statement. "More importantly, we have enhanced our ability to deliver patient-specific pan-omic information and, ultimately, improve disease diagnosis and therapy." 

"By combining DNA sequencing, RNA sequencing, and protein expression utilizing mass spectrometry, NantOmics can now offer expanded testing capabilities that provide a broader and more comprehensive picture of a patient's unique tumor biology," OncoPlex CSO Todd Hembrough added.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.